This article is more than 5 years old. Information may no longer be current.
Zeiss introduces IOLMaster 700 to US market at AAO meeting
Click Here to Manage Email Alerts
LAS VEGAS — The Carl Zeiss Meditec IOLMaster 700 with swept-source biometry is now available in the U.S.
According to a company presentation at the American Academy of Ophthalmology annual meeting, the IOLMaster 700 is designed to reduce the risk of refractive surprise, optimize refractive outcomes and enhance clinical workflow.
Also introduced at the meeting were two new fundus cameras, the Visucam 224 and the Visucam 524, both featuring fundus autofluorescence. Additionally, the Visucam 524 offers fluorescein angiography and optional indocyanine green angiography.
“Carl Zeiss Meditec AG is a world-leading medical technology company operating in two medical fields – ophthalmology and microsurgery. We drive progress in medicine, enabling doctors to achieve the best possible outcomes in their patients,” Ludwin Monz, PhD, MBA, CEO of Zeiss, said in the briefing.
Zeiss is the first company to receive 510(k) clearance from the FDA for its OCT angiography platform, the AngioPlex OCT. Using the Cirrus HD-OCT system, AngioPlex allows for deep visualization of retinal and choroidal blood flow without the need for injected contrast.
“Acquisition of ultra-clear 3D microvascular images of the retina can complement conventional fluorescein angiograms and be a safe and efficient part of routine eye care, allowing for earlier detection and management of micro-progressions,” Ralf Kuschnereit, MD, head of Zeiss’s Ophthalmic Systems Division, said in the presentation.
With regard to the ReLEx SMILE laser vision correction procedure, the fourth and last module of premarket approval application was filed in October, according to the presentation. — by Kristie L. Kahl
Disclosure: Kuschnereit reports he is head of the Ophthalmic Systems Division at Carl Zeiss Meditec AG. Monz reports he is CEO of Carl Zeiss Meditec AG.